Disclosure Of Cash Flow Statement [Text Block]

Ascelia Pharma - Filing #678716

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Disclosure of cash flow statement [text block]
Description of accounting policy for determining components of cash and cash equivalents [text block]
Som
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
21 855 SEK
149 555 SEK
261 599 SEK
Income taxes paid (refund) [abstract]
Income taxes paid (refund), classified as operating activities
1 172 SEK
3 772 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.